![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication October 12, 2007.
Revised December 22, 2007.
Accepted for publication December 27, 2007.
In the mammalian cortex
2 subunit-containing glycine receptors (GlyRs) mediate tonic inhibition, but the precise functional role of this form of GlyRs is difficult to establish because of the lack of subtype-selective antagonist. In this study, we found that cyclothiazide (CTZ), an epilepitogenic agent, potently inhibited GlyR-mediated current (IGly) in cultured rat hippocampal neurons. The inhibition was glycine concentration-dependent, suggesting a competitive mechanism. Notably, when heterologously expressed in HEK293T cells, GlyRs containing the
2 but not
1 or
3 subunit were inhibited by CTZ, indicating subunit specificity of CTZ action. In addition, the degree of CTZ inhibition on IGly in rat spinal neurons declined with time in culture, in parallel with a decline of
2 subunit expression, which is known to occur during spinal cord development. Furthermore, site-directed mutagenesis indicates that a single amino acid threonine at position 59 near the N-terminal of the
2 subunit confers the specificity of CTZ action. Thus CTZ is a potent and selective inhibitor of
2-GlyRs, and threonine 59 site plays a critical role in the susceptibility of GlyR to CTZ inhibition.
Key words:
Glycine, Ion channel regulation, Mutagenesis/Chimeric approaches